Positive Allosteric Modulation of Native and Recombinant γ-Aminobutyric AcidB Receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its Aldehyde Analog CGP13501
- 1 November 2001
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 60 (5) , 963-971
- https://doi.org/10.1124/mol.60.5.963
Abstract
The compounds CGP7930 [2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol] and its close analog CGP13501 were identified as positive modulators of γ-aminobutyric acidB (GABAB) receptor function. They potentiate GABA-stimulated guanosine 5′-O-(3-[35S]thiotriphosphate) (GTPγ[35S]) binding to membranes from a GABAB(1b/2) expressing Chinese hamster ovary (CHO) cell line at low micromolar concentrations and are ineffective in the absence of GABA. The structurally related compounds propofol and malonoben are inactive. Similar effects of CGP7930 are seen in a GTPγ[35S] binding assay using a native GABAB receptor preparation (rat brain membranes). Receptor selectivity is demonstrated because no modulation of glutamate-induced GTPγ[35S] binding is seen in a CHO cell line expressing the metabotropic glutamate receptor subtype 2. Dose-response curves with GABA in the presence of different fixed concentrations of CGP7930 reveal an increase of both the potency and maximal efficacy of GABA at the GABAB(1b/2) heteromer. Radioligand binding studies show that CGP7930 increases the affinity of agonists but acts at a site different from the agonist binding site. Agonist affinity is not modulated by CGP7930 at homomeric GABAB(1b) receptors. In addition to GTPγ[35S] binding, we show that CGP7930 also has modulatory effects in cellular assays such as GABAB receptor-mediated activation of inwardly rectifying potassium channels in Xenopus laevis oocytes and Ca2+ signaling in human embryonic kidney 293 cells. Furthermore, we show that CGP7930 enhances the inhibitory effect ofl-baclofen on the oscillatory activity of cultured cortical neurons. This first demonstration of positive allosteric modulation at GABAB receptors may represent a novel means of therapeutic interference with the GABA-ergic system.Keywords
This publication has 37 references indexed in Scilit:
- Allosteric interactions between GB1 andGB2 subunits are required for optimalGABAB receptor functionThe EMBO Journal, 2001
- Mapping the Agonist-binding Site of GABAB Type 1 Subunit Sheds Light on the Activation Process of GABABReceptorsPublished by Elsevier ,2000
- GABAB Receptors: A New Paradigm in G Protein SignalingMolecular and Cellular Neuroscience, 2000
- l -Amino acid sensing by the extracellular Ca 2+ -sensing receptorProceedings of the National Academy of Sciences, 2000
- Ca2+ Requirement for High-Affinity γ-Aminobutyric Acid (GABA) Binding at GABAB Receptors: Involvement of Serine 269 of the GABABR1 SubunitMolecular Pharmacology, 2000
- Functional pharmacology of cloned heterodimeric GABAB receptors expressed in mammalian cellsBritish Journal of Pharmacology, 1999
- The heteromeric GABA-B receptor recognizes G-protein α subunit C-terminiNeuropharmacology, 1999
- GABAB receptors: drugs meet clonesCurrent Opinion in Neurobiology, 1998
- The effects of saponin on the binding and functional properties of the human adenosine A1receptorBritish Journal of Pharmacology, 1996
- Molecular Cloning, Functional Expression and Pharmacological Characterization of the Human Metabotropic Glutamate Receptor Type 2European Journal of Neuroscience, 1995